Alnylam gets FDA OK to restart hemophilia drug trial after patient's death
December 15, 2017 at 10:16 AM EST
The Cambridge biotech says the FDA had lifted a clinical hold that was announced in September.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|